Balloon-expandable versus self-expanding transcatheter aortic valve replacement: a comparison and evaluation of current findings.
Giuliano CostaEnrico CriscioneClaudia ReddavidMarco BarbantiPublished in: Expert review of cardiovascular therapy (2020)
Although currently available TAVs showed similar mid-term outcomes, the expansion of TAVR indications toward lower risk, younger patients imposes attention to long-term durability, and to the need of obtaining optimized EOAs and an easy coronary re-access for future percutaneous interventions.
Keyphrases
- transcatheter aortic valve replacement
- aortic stenosis
- ejection fraction
- aortic valve
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- coronary artery disease
- physical activity
- minimally invasive
- prognostic factors
- peritoneal dialysis
- left ventricular
- coronary artery
- type diabetes
- patient reported outcomes
- metabolic syndrome
- working memory
- heart failure
- current status
- atrial fibrillation
- ultrasound guided
- skeletal muscle